ATMP BIO: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ATMP BIO
Largest movements
- Cash -€3,728
down €3,728 (-1.9%), from €200,000 to €196,272
mainly Trade debts (-€2,766) and Net result for the year (-€2,002)
- Other debts +€2,783
new in 2025: €2,783
- Trade debts -€2,766
down €2,766 (-99.4%), from €2,783 to €17
- Profit (loss) carried forward -€2,002
down €2,002 (-71.9%), from -€2,783 to -€4,786
- Gross operating margin +€1,368
up €1,368 (+49.1%), from -€2,783 to -€1,416
- Other operating charges +€400
new in 2025: €400
- Financial charges +€188
new in 2025: €188
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €200,000 | €198,015 | -€1,985 | -1.0% |
| Current assets | 29/58 | €200,000 | €198,015 | -€1,985 | -1.0% |
| Cash at bank and in hand | 54/58 | €200,000 | €196,272 | -€3,728 | -1.9% |
| Deferred charges and accrued income | 490/1 | - | €1,742 | +€1,742 | |
| Total equity and liabilities | 10/49 | €200,000 | €198,015 | -€1,985 | -1.0% |
| Equity | 10/15 | €197,217 | €195,214 | -€2,002 | -1.0% |
| Contributions | 10/11 | €200,000 | €200,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€2,783 | -€4,786 | -€2,002 | -71.9% |
| Amounts payable | 17/49 | €2,783 | €2,800 | +€17 | +0.6% |
| Amounts payable within one year | 42/48 | €2,783 | €2,800 | +€17 | +0.6% |
| Trade debts | 44 | €2,783 | €17 | -€2,766 | -99.4% |
| Suppliers | 440/4 | €2,783 | €17 | -€2,766 | -99.4% |
| Other amounts payable | 47/48 | - | €2,783 | +€2,783 | |
| Other operating charges | 640/8 | - | €400 | +€400 | |
| Gross operating margin | 9900 | -€2,783 | -€1,416 | +€1,368 | +49.1% |
| Operating profit (loss) | 9901 | -€2,783 | -€1,815 | +€968 | +34.8% |
| Financial income | 75/76B | - | €1 | +€1 | |
| Recurring financial income | 75 | - | €1 | +€1 | |
| Financial charges | 65/66B | - | €188 | +€188 | |
| Recurring financial charges | 65 | - | €188 | +€188 | |
| Profit (loss) for the period before taxes | 9903 | -€2,783 | -€2,002 | +€781 | +28.1% |
| Profit (loss) for the period | 9904 | -€2,783 | -€2,002 | +€781 | +28.1% |
| Profit (loss) for the period to be appropriated | 9905 | -€2,783 | -€2,002 | +€781 | +28.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.